789O Neoadjuvant Cemiplimab in Patients (pts) with Stage II–IV (M0) Cutaneous Squamous Cell Carcinoma (CSCC): Primary Analysis of a Phase II StudyN. Gross,D. M. Miller,N. Khushanlani,V. Divi,E. S. Ruiz,E. J. Lipson,F. Meier,Y. B. Su,P. L. Swiecicki,J. L. Atlas,J. L. Geiger,A. Hauschild,J. H. Choe,B. G. M. Hughes,S-Y. Yoo,K. Fenech,M. D. Mathias,H. Han,M. G. Fury,D. RischinANNALS OF ONCOLOGY（2022）引用 0|浏览26暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
